Minimally invasive suturing
for vascular and
heart defect closure
Novelrad has developed a micro sewing machine that can deploy a range
of continuous suture patterns, percutaneously, with a simple click of a button.
The versatile suturing platform mimics the surgical ‘gold standard’ and
can address multiple indications in the cardiovascular system and beyond.
Novelrad has developed a micro sewing machine that can deploy a range of continuous suture patterns, percutaneously, with a simple click of a button.
The versatile suturing platform mimics the surgical ‘gold standard’ and can address multiple indications in the cardiovascular field and beyond.
Our solution for large
bore vascular closure
A percutaneous suturing device for closing vascular access
sites following catheterization procedures.
The device deploys a multipoint purse string suture at the
beginning of the procedure, thereby, enabling safe dilation
and reliable closure at the end of the procedure.
The Novelrad VCD features an unprecedented range
of bore sizes using a single device
sites following catheterization procedures.
The device deploys a multipoint purse string suture at the
beginning of the procedure, thereby, enabling safe dilation
and reliable closure at the end of the procedure.
The Novelrad VCD features an unprecedented range
of bore sizes using a single device
Team
Netanel Sharabani
Co-founder & CEO
Over 15 years of experience leading research and development, operations, quality and regulatory in medical device companies. Netanel has versatile experience with the development of medical device including drug delivery, respiratory care, and implantable devices. Prior to Co-founding Novelrad he served as COO, leading an R&D and operation team, at NLT-Spine.
Netanel holds a B.Sc in mechanical engineering from Ben-Gurion University and MBA, double major in finance and strategy from Tel-Aviv University.
Netanel holds a B.Sc in mechanical engineering from Ben-Gurion University and MBA, double major in finance and strategy from Tel-Aviv University.
Shachar Rotem
Co-founder & CTO
Over 25 years of experience in the medical device industry, promoting innovation, managing R&D teams, and IP portfolios.
His experience Includes extensive knowledge in the development of complex miniature electromechanical mechanisms, MEMS, physical algorithms, complex hydraulic components, design and production of plastic articles, hardware, and software architecture (HLD), human-machine interfaces (HMI), FEA and regulatory and risk management. Shachar has over 20 registered patents in the field of medical devices.
Shachar holds a BSc in mechanical engineering from the Technion institute.
His experience Includes extensive knowledge in the development of complex miniature electromechanical mechanisms, MEMS, physical algorithms, complex hydraulic components, design and production of plastic articles, hardware, and software architecture (HLD), human-machine interfaces (HMI), FEA and regulatory and risk management. Shachar has over 20 registered patents in the field of medical devices.
Shachar holds a BSc in mechanical engineering from the Technion institute.
Ori Goldor
Co-founder & R&D Director
Over 20 years of experience in the medical device industry as an engineer, product manager, and consultant.
Ori has vast experience in the development of medical devices, from inception, including wide experience in the development of cardiovascular applications.
Before co-founding Novelrad Ori served as the engineering manager at Cardiodex and as an independent R&D consultant for medical device start-ups and growth companies.
Ori holds a BSc in mechanical engineering from the Technion institute.
Ori has vast experience in the development of medical devices, from inception, including wide experience in the development of cardiovascular applications.
Before co-founding Novelrad Ori served as the engineering manager at Cardiodex and as an independent R&D consultant for medical device start-ups and growth companies.
Ori holds a BSc in mechanical engineering from the Technion institute.
Dr. Elchanan Bruckheimer, MBBS
CMO
Dr. Elchanan Bruckheimer is a leading pediatric cardiologist and Director of the Cardiac Catheterization Laboratories at Schneider Children's Medical Centre, Israel. He is an expert in interventional cardiology for the treatment of congenital and structural heart disease and serves regularly on faculty at leading international meeting including TCT PICS-AICS, CSI, ICI and the Veith symposium).
Dr. Bruckheimer holds a degree in medicine (University of London) with specialization in pediatric cardiology (Yale University).
Dr. Bruckheimer holds a degree in medicine (University of London) with specialization in pediatric cardiology (Yale University).
Ran Kaspi
CFO
Ran is a CFO with over 15 years of experience. As CFO, Ran led the listing of Real Luck Group Ltd. (LUCK. V) on the Canadian Stock Exchange, and the listing of Delta Drone International Limited (DLT. AX) on the Australian Stock Exchange. He served as Global E-Online’ s first Finance Director (NASDAQ: GLBE) and led the Economic & Performance team at 888 (LSE: 888.L).
Ran holds a B.A. in Economics (Ruppin Academic Center) and an M.B.A. Finance & Strategy (Tel Aviv University)
Ran holds a B.A. in Economics (Ruppin Academic Center) and an M.B.A. Finance & Strategy (Tel Aviv University)
